Serine protease inhibitor kazal-type 6 inhibits tumorigenesis of human hepatocellular carcinoma cells via its extracellular action

Hepatocellular carcinoma (HCC) causes significant medical burdens worldwide. Diagnosis, especially in the early stages, is still challenging. Therapeutic options are limited and often ineffective. Although several risk factors have been known important for development of HCC, the molecular basis of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ge, Kuikui, Huang, Jinjiang, Wang, Wei, Gu, Meigang, Dai, Xinchuan, Xu, Yuqiang, Wu, Hongyu, Li, Guodong, Lu, Hairong, Zhong, Jiang, Huang, Qingshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351605/
https://www.ncbi.nlm.nih.gov/pubmed/27999203
http://dx.doi.org/10.18632/oncotarget.13983

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5351605/
https://www.ncbi.nlm.nih.gov/pubmed/27999203
http://dx.doi.org/10.18632/oncotarget.13983

Ejemplares similares